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Abstract
Despite the multifactorial etiology of prematurity, intra-amniotic infection is 
present in 25–40% of preterm pregnancies. Bacteria in amniotic cavity synthesize 
phospholipases associated with the production of prostaglandins that leads to 
rupture of fetal membranes and uterine contractions. Bacterial pathogen-associated 
molecular patterns (PAMPs) activate pattern recognition receptors (PRRs) such as 
Toll-like (TLRs) and NOD-like receptors (NLRs), triggering pathways that cul-
minate in the production of cytokines that further increase prostaglandin release. 
Importantly, endogenous molecules called damage-associated molecular patterns 
(DAMPs) released under stressful conditions can also activate PRRs. Risk fac-
tors for both preterm labor (PTL) and preterm premature rupture of membranes 
(PPROM), including infection-induced inflammation, may cause an increase of 
ROS release and depletion of antioxidant defenses. In spite of the similarity between 
the pathophysiology of PTL and PPROM, there are significant differences regard-
ing molecular mediators, degree of tissue damage, and oxidative stress present in 
these two conditions. PPROM seems to be a consequence of notable tissue damage 
resulting from chronic oxidative stress, while PTL is associated with minimal tissue 
degradation resulting from acute exposure and greater antioxidant status. A better 
understanding of prematurity pathophysiology and the differences between PTL 
and PPROM can benefit therapeutic approaches to prevent these important inflam-
matory syndromes.
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1. Introduction
Innate immune responses play a critical role at different stages of gestation, and 
a successful pregnancy depends on the balance between anti- and pro-inflamma-
tory molecules. In addition, normal pregnancy is marked by increased oxidative 
stress, due to increased fetal metabolism, decreased maternal antioxidant reserves, 
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or maternal supply of substrate. Disruption of these two major mechanisms, 
inflammation and oxidative stress, is closely linked to spontaneous prematurity.
2. Innate immunity and pattern recognition receptors (PRRs)
Innate immunity is a primordial defense system implicated in the identification 
and eradication of infectious agents that also recognizes products from damaged 
cells and works to eliminate them. The innate immune system acts through the 
recognition of molecular structures common to microorganisms, called pathogen-
associated molecular patterns (PAMPs) and endogenous molecules called damage-
associated molecular patterns (DAMPs) [1], which are passively released from 
damaged and dying cells, or actively secreted by immune cells or severely stressed 
cells [2].
PAMPs and DAMPs are recognized by pattern recognition receptors (PRRs) 
expressed by several cell types [1, 3]. Their ubiquitous localization in cells 
enables PRRs to recognize microorganisms present in distinct compartments. 
Membrane-bound PRRs are located in the plasma membrane, endosomal and 
lysosomal membranes, while cytosolic PRRs are located in the cytoplasm of 
cells [1, 3].
Toll-like receptors (TLR) are PRRs coupled to the cell membrane [4], composed 
of type I integral membrane glycoproteins, comprised of an ectodomain with a 
leucine-rich repeat domain (LRR), an endodomain with Toll/IL-1 receptor (TIR), 
that shares a 200-amino acid conserved region with interleukin-1 (IL-1) and IL-18 
receptors, and a short transmembrane domain [1, 5]. The ectodomain recognizes 
specific PAMPs, while the endodomain recruits adaptor molecules, enabling the 
intracellular cascade [5].
The first group of TLRs is responsible for the recognition of structural compo-
nents of microorganisms and comprises receptors expressed on the cell surface, 
including TLR-1, TLR-2, TLR-4, TLR-5, TLR-6, and TLR-11 [4]. The second group 
includes receptors exclusively expressed in intracellular vesicles, TLR-3, TLR-7, and 
TLR-9, which recognize nucleic acids from microorganisms [4, 6].
PAMPs’ recognition by TLRs activates intracellular pathways that lead to the 
activation of transcription factors responsible for the expression of genes involved 
in inflammatory and antiviral responses [1, 5, 6]. Among the transcription factors 
activated by TLR signaling, the most common factors are nuclear factor kappa-B 
(NF-κB), activating protein 1 (AP-1), interferon regulatory factor 3 (IRF3), and 
IRF7 [1]. Activation of NF-κB and AP-1 results in the transcription of several genes 
of pro-inflammatory effector molecules, such as cytokines and chemokines, while 
the activation of IRF3 and IRF7 leads to the production of type I interferons that are 
involved in antiviral immunity [1, 3].
Intracellular signaling through NF-κB and AP-1 is very well character-
ized [4, 7], and TLR-4 and TLR-9 are shown as examples of TLRs on the cell 
surface and in endosomes, respectively, in Figure 1. The activation of TLRs by 
PAMPs and DAMPs triggers the formation of a signaling complex, a myddo-
some, composed of protein MyD88 and interleukin-1 receptor-associated kinase 
1 (IRAK1) and IRAK4, leading to activation of pro-inflammatory transcription 
factors, NF-kB and AP-1.
Although infection is the main stimulus for inflammation, it can also be induced 
in sterile conditions [8]. Therefore, DAMPs are as important to sterile inflamma-
tion as PAMPs are to innate response to microorganisms. DAMPs are endogenous 
factors that in physiologic conditions are protected from cellular receptors. During 
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tissue damage, DAMPs are liberated from cells and are recognized by immune cells 
[9]. DAMPs can also be actively secreted by immune and severely stressed cells [2]. 
Evidence shows that PAMPs and DAMPs act in different ways to stimulate innate 
immunity. Antigen-presenting cells that are unresponsive to lipopolysaccharide 
(LPS) can be activated by necrotic cells, indicating that TLR-4 activation, regard-
less of LPS, occurs in response to endogenous ligands [10]. Similarly, TLR-3 recog-
nizes cells that undergo necrosis during acute inflammatory events, independently 
of the presence of viral PAMPs [11].
Among the cytosolic PRRs, nucleotide-binding oligomerization domain (NOD)-
like receptors (NLRs) are of great importance [1]. The NLR family is a class of 
intracellular receptors that lead to intracellular signaling associated to inflamma-
tion, after recognition of PAMPs and DAMPs [1]. Members of the NLR family are 
characterized by at least three domains: the first one is an LRR domain, responsible 
for the recognition of the ligand; the second is a NACHT domain that allows the 
formation of oligomers of NLRs; and the third is the effector domain, usually a 
Figure 1. 
Overview of TLR signaling pathways. Activation of TLRs on the cell surface or endosomal membranes and 
formation of myddosome complex, leading to activation of pro-inflammatory transcription factors NF-kB and 
AP-1. Communication between TLR and the myddosome occurs through interaction of the TIR domain of the 
Toll-like receptor with the TIR domain of MyD88 and depends on the adapter molecule called MAL, allowing 
the myddosome to form a helical structure. IRAK-4 activates IRAK-1, which undergoes autophosphorylation. 
Phosphorylated IRAK-1 then binds to TRAF-6, resulting in the activation of the TAK-1, which results in 
activation of the cascade of KKs that phosphorylate the inhibitory protein of NF-kB, leading to activation 
of NF-kB. Additionally, the activation of TAK-1 protein also results in activation of MAPKs, leading to 
activation of the transcription factor AP-1. AP-1, activator protein 1; IKK, IκB kinase; IRAK, interleukin-1 
receptor-associated kinase; MAL, MyD88-adapter-like protein; MAPK, mitogen-activated protein 
kinase; MYD88, myeloid differentiation primary response protein 88; TAB, TAK1-binding protein; TAK1, 
transforming growth factor β (TGF-β)-activated kinase 1; TRAF6, tumor necrosis factor receptor-associated 
factor 6. Adapted from Kawasaki and Kawai [4].
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caspase recruitment domain (CARD), responsible for the recruitment of accessory 
proteins [12].
The first NLRs described were NOD-1 and NOD-2 [13], which recognize pep-
tides from degradation of peptidoglycan (PG) that occurs during bacterial growth 
or destruction. Recognition of PGs by NOD-1 and NOD-2 leads to activation of 
intracellular pathways, which activate the transcription factor NF-κB, and results in 
the synthesis of several inflammatory cytokines [14, 15].
Members of the NLR family known as NLRP are capable of responding to 
cytoplasmic PAMPs and DAMPs through the formation of intracellular signaling 
complexes, termed inflammasomes [1]. Inflammasomes activate proteases from the 
caspase family during immune regulation in physiologic and pathologic conditions 
[16]. The typical structure of the inflammasome consists of NLRP, adaptor protein 
apoptosis-associated speck-like protein containing a CARD (ASC; also known 
as PYCARD), and pro-caspase [17]. This transient oligomer starts a cascade that 
culminates with activation of caspase-1 and production of the active form of IL-1β 
[18] and IL-18 [19].
The inflammasome NLRP3 is activated in response to several PAMPs, such as 
flagellin, muramyl dipeptide, LPS, and pore-formation toxins [1]. Moreover, it can 
be activated by DAMPs, reactive oxygen species (ROS), and environmental signals 
[16, 20]. Three models describing mechanisms of NRLP3 inflammasome activation 
have been suggested, which may not be mutually exclusive [21–23] (Figure 2). In 
the absence of activation mechanisms, NLRP3 inflammasome complex is autore-
pressed, owing to an interaction between NATCH domains and LRRs. When one or 
Figure 2. 
Mechanisms of NLRP3 inflammasome activation. PAMPs and DAMPs are able to induce the activation of the 
NLRP3 inflammasome by three principal mechanisms: (A) high concentrations of extracellular ATP lead to 
opening of PANX1 channels by binding to the P2X7 receptor, which results in K+ efflux and influx of PAMPs 
and DAMPs; (B) phagocytosis of PAMPs and DAMPs leads to disruption of the lysosomal membrane and 
consequent release of a putative NLRP3-activating molecule, such as cathepsin B; and (C) PAMPs and DAMPs 
can induce the production of ROS, which may active TXNIP to trigger NLRP3 activation. Activation of the 
NLRP3 inflammasome results in maturation of caspase-1 and release of mature forms of IL-1 and IL-18. ATP, 
adenosine triphosphate; DAMPS, damage-associated molecular patterns; LRR, leucine-rich repeat domain; 
PAMPs, pathogen-associated molecular patterns; PANX1, pannexin-1; ROS, reactive oxygen species; TXNIP, 
thioredoxin-interacting protein. Adapted from Tschopp and Schroder [23].
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more activation mechanism is present, this autorepression is removed, resulting in 
NATCH domain exposure. After this exposure, NLRP3 oligomerizes and recruits 
ASC and pro-caspase 1, leading to activation of caspase 1 and, consequently, matu-
ration and secretion of IL-1β and IL-18 [21, 22]. The immune response initiated 
by inflammasome activation shows a close relationship with both physiologic and 
pathologic processes, as immunological defense and development of inflammatory 
diseases [20].
3. Pregnancy, maternal immunity, and oxidative stress
During pregnancy, a tightly regulated immune system allows for fetal survival 
and its adequate development. Among the several modifications made by the 
maternal immune system to raise tolerance to the allograft fetus, changes in cyto-
kine profiles at the maternal-fetal interface are of great importance [24].
Recent data have shown that a successful pregnancy depends on a complex 
balance between anti- and pro-inflammatory molecules that changes through-
out pregnancy [25, 26]. First trimester is characterized by prevalence of the 
T helper cell type 1 (Th1) profile. During this stage, an inflammatory micro-
environment is necessary for repair and remodeling of the uterine epithelium 
damaged during implantation and for removal of cellular debris [27]. In the 
second trimester, there is a prevalence of a Th2 profile [28–30]. The increased 
anti-inflammatory activity is important for maintenance of gestation. During 
the third trimester and labor, the Th1 profile is again predominant systemi-
cally [31] in the placental tissue and amniotic fluid, supporting the theory 
that proinflammatory overload in the intrauterine environment is required for 
initiation and progression of labor [32, 33]. The final trimester is character-
ized by an influx of immune cells at the maternal-fetal interface and increased 
production of pro-inflammatory cytokines [34, 35]. This scenario is essential for 
the development of the physiologic processes of cervical remodeling, weakening 
and rupture of fetal membranes, and initiation of uterine contractility, which 
together culminate in labor [36, 37].
Recent studies have also demonstrated that normal pregnancy is marked by 
increased oxidative stress, due to increased fetal metabolism, decreased fetal 
antioxidant reserves, or maternal supply of substrate [38, 39]. Oxidative stress 
results from exacerbated production of ROS and/or decreased production of 
antioxidants. Increased oxidative stress has been described in the third trimester 
of normal pregnancies and labor [38]. During the process of labor, the intensity 
of uterine contractions increases uterus pressure and can cause interruption or 
reduction in the uteroplacental blood flow, causing cycles of cellular hypoxia and 
reoxygenation. These events of parturition are responsible for inducing increased 
oxidative stress in pregnant women, which must be controlled by their antioxidant 
system [40, 41].
3.1 Prematurity, inflammatory response, and oxidative stress
Prematurity is the leading cause of neonatal mortality and is also responsible 
for several short- and long-term morbidities. The risk for these complications is 
inversely proportional to gestational age at birth [42–44]. Preterm delivery (PTD) 
is defined as birth before 37 weeks of gestation, and the incidence of PTD among 
singleton pregnancies is 9.6% worldwide [45]. Spontaneous PTD can be divided 
into PTD, which is preceded by preterm labor (PTL) with intact membranes, or 
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by preterm premature rupture of membranes (PPROM) [43, 46]. The incidence of 
PTL is approximately 60 and 30–40% for PPROM [27, 35, 47].
The etiology of prematurity is multifactorial and includes maternal, paternal, 
and genetic risks [48–52], as summarized in Table 1. Despite this multifacto-
rial etiology, studies show that intra-amniotic infections (IAI) are present in 
25–40% of preterm pregnancies; however, these frequencies are believed to be 
 underestimated [43, 53].
The main infection route into the amniotic cavity (AC) is the ascending of bacte-
ria present in the lower genital tract through the endocervical canal. Ascending 
bacteria can then cross the membranes and invade the AC, with subsequent prolif-
eration in the amniotic fluid. Once microorganisms reach this site, they may travel 
to the amnion, connective tissue, and even chorion and decidua [54]. The establish-
ment of inflammation in the chorioamniotic membranes in response to bacteria is 
called chorioamnionitis. Clinical chorioamnionitis (cCAM) occurs in 1–2% of term 
labors and in 5–10% of PTLs, and this prevalence increases in case of PPROM due to 
Maternal
Sociodemographic characteristics African-American ethnicity
Extreme maternal ages
Low socioeconomic index
Smoking
Drugs and alcohol abuse
Clinical and gynecological history Previous prematurity
Diabetes
Hypertension
Cervical cone biopsy
Gestational characteristics Multiple gestation pregnancies
Placenta previa
Placenta abruption
Preeclampsia
Polyhydramnios or oligohydramnios
Uterine and cervical anomalies
Assisted conception
Infections
Bacterial vaginosis
 Periodontal infection
 Chlamydial infection
 Intrauterine infection
Paternal High paternal age
Genetics Polymorphisms IL-1R,IL-1β, IL-6, IL-10, MMP-1, MMP-9, 
TLR-4, TNF-α, HPS47
IL-1R, interleukin 1 receptor; IL-1β, interleukin 1 beta; IL-6, interleukin 6; IL-10, interleukin 10; MMP-1, matrix 
metalloproteinase 1; MMP-9, matrix metalloproteinase 9; TLR-4, Toll-like receptor 4; TNF-α, tumor necrosis factor 
alpha; HPS47, heat shock protein 47.
Table 1. 
Risk factors for spontaneous prematurity.
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the compromised immune status of the fetal membranes [55]. Histological chorio-
amnionitis (hCAM) is defined by the presence of polymorphonuclear cells (PMN) 
in the chorioamniotic membranes. Most cases of hCAM are not followed by clinical 
signals and symptoms of infection; however, the diagnosis is made in approximately 
20% of term pregnancies and over 50% of PTLs [56–58].
The main microorganisms found in the AC of pregnant women with IAI are 
Ureaplasma urealitycum, Mycoplasma hominis, and Fusobacterium sp. Gram-negative 
bacilli such as Bacteroides sp. and Prevotella sp. are also occasionally found, along 
with Escherichia coli, Gardnerella vaginalis, and group B Streptococcus [59–61].
The main mechanism by which IAI leads to prematurity is through the produc-
tion of prostaglandins. Bacteria present in amniotic fluid synthesize phospholipases 
that, in turn, activate the liberation of arachidonic acid that is metabolized via 
cyclooxygenase, culminating in the production of prostaglandins. Concomitantly, 
activation of TLRs and NLRs by PAMPs present in these bacteria initiates produc-
tion and release of inflammatory cytokines, which increase the release of prosta-
glandins by macrophage, decidual, and amniotic cells [62, 63].
PTL and PPROM pathways are similar in etiology; however, according to 
Menon et al. [64], the major difference is the presence of molecular factors 
associated with infection, such as metalloproteinases and pro-apoptotic factors 
that are responsible for structural modifications and weakening of fetal mem-
branes in patients undergoing PPROM. These same factors are absent or mini-
mally expressed in PTL. Other differences between PTL and PPROM include the 
distinct response to microorganisms present in the AC [65–67] and the intensity 
of the inflammatory response [68].
Recently, new data have demonstrated the participation of oxidative stress in 
the physiopathology of PPROM [69, 70], suggesting that this pathology is similar 
to term pregnancies with regard to degradation, apoptotic signals, oxidative stress, 
and premature aging of fetal membranes [71, 72]. Increased levels of oxidative 
stress markers have been not only associated with the third trimester of normal 
pregnancy and labor [73] but also observed during second trimester pregnancy 
disorders, such as preeclampsia and low birth weight [74]. Hence, early senes-
cence, a mechanism leading to fetal membrane aging and immunological dysfunc-
tion, is a feature of PPROM [72, 75, 76]. Risk factors for both PTL and PPROM, 
including infection-induced inflammation, may cause an increase of ROS release 
and depletion of antioxidant defenses [76, 77]. In this way, Menon suggests that 
PPROM is characterized by pronounced tissue damage resulting from oxidative 
stress and proteolysis, while PTL has minimal tissue damage [76]. The greater 
tissue damage present in PPROM may be a consequence of chronic exposure to 
oxidative stress risk factors. PTL, in turn, may result from acute oxidative stress 
associated with a better antioxidant status, a scenario in which the capacity of cell 
resistance is maintained, while the inflammatory response required for initiation 
of labor pathway is preserved. PPROM also differs from PTL in its molecular 
signature linked to senescence of fetal membranes, where premature aging and 
tissue injury cause DAMPs’ release from fetal membranes, which can also contrib-
ute to rupture and secondary invasion of microbes due to an immunocompromised 
environment. Therefore, sterile inflammation by senescent fetal tissues is also a 
major contributor to PPROM pathology. We have reported differences in antioxi-
dants, telomere length (marker of aging), F2-isoprostanes (markers of oxidative 
lipid peroxidation), and senescence-associated β-galactosidase (senescence) in 
fetal membranes and amniotic fluid between PPROM and spontaneous preterm 
births without PPROM, illustrating the molecular differences between the two 
phenotypes [75, 78, 79].
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3.2  TLRs and NLRs at the maternal-fetal interface and pregnancy complicated 
by chorioamnionitis and prematurity
Regarding the maternal-fetal interface, expression of TLRs has mainly been 
investigated in chorioamniotic membranes and the placenta. TLR-2 and TLR-4 
are able to recognize most PAMPs present in pathogens involved in AC infections, 
which are associated with precocious activation of inflammatory response in 
amniochorionic membranes. Due to this, they are evaluated in most studies con-
cerning TLR expression at maternal-fetal interface.
TLR-2 recognizes microbial lipoproteins, peptidoglycans, and lipoteichoic acid 
from Gram-positive bacteria, lipoarabinomannan from mycobacteria, zymosan 
from fungi, and hemagglutinin from smallpox virus [80]. The large capacity of 
recognition shown by TLR-2 can be explained by its ability to form heterodimers 
with TLR-1 and TLR-6. The heterodimer TLR-1/TLR-2 recognizes tri-acetylated 
lipopeptides, while TLR-2/TLR-6 recognizes zymozan and diacetylated lipopep-
tides [80, 81]. TLR-4 recognizes LPS from Gram-negative bacteria, an important 
macrophage activator and initiator of septic shock [82].
Kim et al. [83] showed increased expression of TLR-2 in chorioamniotic mem-
branes with hCAM. Our group provided the first report of increase in TLR-1 and 
TLR-2 mRNAs in fetal membranes of preterm pregnancies with hCAM, when 
compared to preterm membranes without hCAM [84]. Kumazaki et al. [32] showed 
that placental macrophages from preterm pregnancies complicated by CAM had 
increased immunoreactivity to TLR-4, when compared to those without inflamma-
tory infiltrate or term placentas. Using immunohistochemistry techniques, Rindsjö 
et al. [85] demonstrated an important reduction in TLR-2 expression in placentas in 
the setting of hCAM and reasoned that the expression of this receptor is probably 
affected by inflammatory processes in the membranes. Moreover, Kacerovsky et al. 
[86, 87] showed that pregnant women with PPROM and microbial invasion of the 
AC had higher levels of soluble TLR-1, TLR-2, TLR-4, and TLR-6 in amniotic fluid.
The expression of TLR-2 and TLR-4 by amniotic epithelium suggests that the 
epithelium not only works as a mechanical barrier against microorganisms but 
also plays an important part in the activation of innate immunity [83]. According 
to Kim et al. [83], the increased expression of these receptors in term membranes 
reinforces the association between labor and inflammation, as described by Keelan 
et al. [88]. This upregulation of TLRs may enhance maternal and fetal protection 
against microbial invasion of the AC. However, Holmlund et al. [89] did not observe 
differences in TLR-2 and TLR-4 expression between trophoblastic cells, stimulated 
with zymozan and LPS, and nonstimulated trophoblasts. A possible explanation is 
that both receptors may be overexpressed in uterine tissue as a defense mechanism, 
which can protect the fetus against infection during pregnancy and labor. Gonzalez 
et al. [90] showed that pregnant and nonpregnant mice present different TLR 
expression in their uterine tissue and that the expression of TLR-2, -3, -4, and -9 
increases throughout pregnancy. This finding is in agreement with those of Beijar 
et al. [91], who reported lower expression of TLR-4 in first trimester villi, when 
compared to term villi. The apparent disagreement among studies may reflect 
differences in response to infection in distinct sites of the placenta and gestational 
tissues.
While several studies showed that gestational tissues express TLRs and are 
capable of responding to pathogens who present TLR-specific ligands, few stud-
ies have discussed the expression of NLRs at the maternal-fetal interface during 
normal and complicated pregnancies [92–97]. Gene expression of NOD1 was 
observed in the placenta of pregnant women at term [92, 93], while first trimester 
placenta villi expressed NOD1 and NOD2 mRNA, both by syncytiotrophoblast and 
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cytotrophoblast cells [94]. This differential expression is also observed function-
ally; the first trimester trophoblast cells trigger an inflammatory response following 
exposure to the NOD1 and NOD2 protein ligands, while trophoblast cells from 
term pregnancies only respond to the NOD1 ligand [94]. Interestingly, Wang et al. 
demonstrated that expression of NOD1 and NOD 2 in placental villi and decidua 
was higher in epithelium than in tissue stroma, reinforcing the idea that epithelial 
tissues are strongly involved in the host defense response at the maternal-fetal 
interface [96].
Regarding chorioamnionitis, Romero et al. [95] observed that the expression 
of NOD2 and NLRP3 in chorioamniotic membranes was higher during labor at 
term in the presence of histologic chorioamnionitis (hCAM), than in membranes 
without hCAM; however, only the NLPR3 protein concentration was increased in 
chorioamniotic membranes in the presence of hCAM. Additionally, Pontillo et al. 
[97] observed that LPS from Gram-negative bacteria increases expression of the 
NLRP3 inflammasome in trophoblast and decidual stromal cells, suggesting that 
this multiprotein complex could be important in placental immune defense against 
invading pathogens.
4. Conclusion
Inflammation and oxidative stress are important to the success of normal 
pregnancy, and their disruption is closely related with pregnancy complications. 
Regarding inflammatory responses, special receptors of the maternal innate 
immune system are capable of responding to microbial ligands present in amniotic 
fluid during intra-amniotic infection, resulting in an exacerbation of inflamma-
tory mediator production, which is associated with the precocious activation of 
the parturition pathway. Additionally, studies have demonstrated the participation 
of oxidative stress in the physiopathology of PPROM, highlighting the similarity 
between PPROM and term pregnancies in relation to degradation and aging of fetal 
membranes. In this way, PPROM would be a consequence of notable tissue dam-
age resulting from chronic oxidative stress, while PTL would be associated with 
minimal tissue degradation, resulting from acute exposure associated with a better 
antioxidant status. This indicates that exacerbation of the maternal inflammatory 
response and oxidative stress operates in an interdependent way in the pathophysi-
ology of spontaneous preterm birth, including PTL and PPROM.
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